Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

HEXO Corp. HEXO NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HEXO Corp. (HEXO) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bearish — 3 Hold, 2 Sell.

HEXO Analyst Ratings

Hold
5
Ratings
3 Hold
2 Sell
Based on 5 analysts giving stock ratings to HEXO Corp. in the past 3 months
Rating breakdown
Hold
3 60%
Sell
2 40%
0%
Buy
0 analysts
60%
Hold
3 analysts
40%
Sell
2 analysts

People Also View

CURLF
CURLF
Curaleaf Holdings, Inc.
$2.40
+0.04%
 CRON
CRON
Cronos Group Inc.
$2.57
+0.78%
 TLRY
TLRY
Tilray Brands, Inc.
$6.91
+2.83%
 CGC
CGC
Canopy Growth Corporation
$1.09
+0.93%
 SNDL
SNDL
SNDL Inc.
$1.44
+5.11%
 ACB
ACB
Aurora Cannabis Inc.
$3.53
+1.44%
 OGI
OGI
Organigram Global Inc.
$1.43
+0.70%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message